ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3032% above fair value
$177.30−0.96 (-0.54%)
Close on Nov 12, 2026Market cap $4.43BP/E 73.6Yield –
ICU Medical gross margin
Gross margin is gross profit as a percentage of revenue.
ICU Medical's gross margin for the twelve months ending Sep 30, 2026 was 40.3%. For fiscal 2025 it was 36.8%, against 34.6% the year before. The highest annual figure on record is 53.1% in fiscal 2016.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.8% | +2.2 |
| FY2024 | Dec 31, 2024 | 34.6% | +1.9 |
| FY2023 | Dec 31, 2023 | 32.8% | +2.1 |
| FY2022 | Dec 31, 2022 | 30.6% | −6.7 |
| FY2021 | Dec 31, 2021 | 37.3% | +1.0 |
| FY2020 | Dec 31, 2020 | 36.3% | −1.0 |
| FY2019 | Dec 31, 2019 | 37.3% | −3.4 |
| FY2018 | Dec 31, 2018 | 40.7% | +7.8 |
| FY2017 | Dec 31, 2017 | 33.0% | −20.1 |
| FY2016 | Dec 31, 2016 | 53.1% | +0.2 |
| FY2015 | Dec 31, 2015 | 52.9% | +4.0 |
| FY2014 | Dec 31, 2014 | 49.0% | −0.4 |
| FY2013 | Dec 31, 2013 | 49.3% | −0.1 |
| FY2012 | Dec 31, 2012 | 49.4% | +2.3 |
| FY2011 | Dec 31, 2011 | 47.1% | +1.5 |
| FY2010 | Dec 31, 2010 | 45.6% | −0.8 |
| FY2009 | Dec 31, 2009 | 46.4% | +2.5 |
| FY2008 | Dec 31, 2008 | 43.9% | +2.3 |
| FY2007 | Dec 31, 2007 | 41.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 41.9% | +4.5 |
| Q2 FY2026 | Jun 30, 2026 | 42.6% | +4.7 |
| Q1 FY2026 | Mar 31, 2026 | 38.9% | +4.1 |
| Q4 FY2025 | Dec 31, 2025 | 37.5% | +1.5 |
| Q3 FY2025 | Sep 30, 2025 | 37.4% | +2.6 |
| Q2 FY2025 | Jun 30, 2025 | 37.9% | +3.1 |
| Q1 FY2025 | Mar 31, 2025 | 34.7% | +2.1 |
| Q4 FY2024 | Dec 31, 2024 | 36.1% | +6.9 |
| Q3 FY2024 | Sep 30, 2024 | 34.8% | +1.5 |
| Q2 FY2024 | Jun 30, 2024 | 34.8% | −0.2 |
| Q1 FY2024 | Mar 31, 2024 | 32.7% | −1.1 |
| Q4 FY2023 | Dec 31, 2023 | 29.2% | −1.1 |
| Q3 FY2023 | Sep 30, 2023 | 33.2% | +2.1 |
| Q2 FY2023 | Jun 30, 2023 | 35.0% | +5.1 |
| Q1 FY2023 | Mar 31, 2023 | 33.8% | +2.7 |
| Q4 FY2022 | Dec 31, 2022 | 30.3% | −7.2 |
| Q3 FY2022 | Sep 30, 2022 | 31.2% | −6.8 |
| Q2 FY2022 | Jun 30, 2022 | 29.9% | −8.5 |
| Q1 FY2022 | Mar 31, 2022 | 31.1% | −4.3 |
| Q4 FY2021 | Dec 31, 2021 | 37.4% | +0.0 |
| Q3 FY2021 | Sep 30, 2021 | 38.0% | +2.3 |
| Q2 FY2021 | Jun 30, 2021 | 38.4% | +3.4 |
| Q1 FY2021 | Mar 31, 2021 | 35.4% | −1.5 |
| Q4 FY2020 | Dec 31, 2020 | 37.4% | +1.2 |
| Q3 FY2020 | Sep 30, 2020 | 35.8% | −2.8 |
| Q2 FY2020 | Jun 30, 2020 | 35.0% | +1.8 |
| Q1 FY2020 | Mar 31, 2020 | 36.9% | −3.9 |
| Q4 FY2019 | Dec 31, 2019 | 36.2% | −3.4 |
| Q3 FY2019 | Sep 30, 2019 | 38.6% | −2.6 |
| Q2 FY2019 | Jun 30, 2019 | 33.3% | −8.9 |
| Q1 FY2019 | Mar 31, 2019 | 40.9% | +0.8 |
| Q4 FY2018 | Dec 31, 2018 | 39.6% | +2.4 |
| Q3 FY2018 | Sep 30, 2018 | 41.1% | +8.6 |
| Q2 FY2018 | Jun 30, 2018 | 42.1% | +15.5 |
| Q1 FY2018 | Mar 31, 2018 | 40.1% | +4.1 |
| Q4 FY2017 | Dec 31, 2017 | 37.1% | −15.9 |
| Q3 FY2017 | Sep 30, 2017 | 32.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 26.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 35.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 53.0% | – |
See a number that looks wrong?